The head of Memorial Sloan-Kettering Cancer Center was accused in a federal lawsuit along with biotechnology company Celgene Corp. of using research he helped develop at another cancer institute to start his own company.

Is this meaningful or just another movement?

BETHESDA, Md., Feb. 2, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX - News) †- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical ...

Research and Markets has announced the addition of Global Markets Direct's new report "Ovarian Cancer - Pipeline

NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce the official opening of its "state of the art" Cold Chain and Logistics (CLS) warehouse in Werne, Germany at an inauguration ceremony attended by local dignitaries and many of ...

NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Animal Biotechnology - Technologies, Markets and Companies http://www.reportlinker.com/p0203534/Animal-Biotechnology---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=BiotechnologyThis ...

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that it will report financial results for the fourth quarter and year ending December 31, 2011 on Thursday, February 9, 2012, after the U.S.

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug.

MALVERN, Pa., Feb. 1, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL - News) today announced that executive management will participate in the Leerink Swann 2012 Global Healthcare Conference ...

EAST BRUNSWICK, N.J., Feb. 1, 2012  /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT - News) today announced that the Company's Board of Directors has appointed David Y. Norton, a member of the Savient ...

Yahoo! News - Search Results for Biotechnology and Pharmaceuticals